Skip to main content

Table 1 Blood-based lipid biomarkers of APOECh carriers and noncarriers

From: Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants

 

EUR Carriers (N=36)

 

EUR Noncarriers (N=129,240)

 

KS test

 

Min, Max

Median

Min, Max

Median

 

Apolipoprotein A

1.03-2.12

1.64

0.52-2.50

1.55

D=0.19 P-value=0.239

Apolipoprotein B

0.65-1.37

0.88

0.40-1.99

1.02

D=0.31 P-value=0.004

Apolipoprotein B (statin adjusted)

0.65-1.37

0.94

0.40-2.76

1.06

D=0.25 P-value=0.036

C reactive protein

0.09-16.48

1.12

0.08-78.26

1.32

D=0.12 P-value=0.662

Cholesterol

3.82-7.83

5.32

1.71-12.50

5.73

D=0.18 P-value=0.263

Cholesterol (statin adjusted)

3.82-7.83

5.80

1.88-15.56

5.91

D=0.15 P-value=0.427

High-density lipoprotein

0.80-2.05

1.56

0.23-4.19

1.47

D=0.2 P-value=0.225

Low-density lipoprotein

2.19-5.06

3.25

0.75-8.86

3.55

D=0.23 P-value=0.072

Low-density lipoprotein (statin adjusted)

2.23-5.06

3.36

0.80-12.96

3.70

D=0.21 P-value=0.119

Lipoprotein A

4.10-178.95

22.00

3.80-189.00

20.50

D=0.11 P-value=0.838

Triglycerides

0.79-6.31

1.71

0.23-11.15

1.42

D=0.16 P-value=0.329

  1. Summary statistics of lipid biomarkers among European APOECh carriers and matched noncarriers. A two-sided Kolmogorov-Smirnov (KS) test was used to determine whether the measurements for a given lipid biomarker follow the same distribution among carriers and noncarriers